BioWorld Asia

Jan. 20, 2010

BioInvent to Get $21M in Directed Share Offer with Little Discount

BioInvent International AB is pocketing around SEK150 million (US$21.2 million) - before expenses - and making two prominent additions to its shareholders' register, via a directed offering of 5,434,800 shares. Read More

Comments from EU Health Chief Designate Has Industry on Edge

Wellcome Trust Offers Bonanza of Sequencing, Genome Data

BioMedPartners Closes $102M Fund for Early- Mid-Stage EU Companies

U.S. Scientific Inventory Shows Asia, EU Gaining in R&D Status

40 UK Companies Will Share in £8.3M Stem Cell Program

Rapid U.S. Biomedical Research Funding Is Dead: JAMA Report

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for April 1, 2026.

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

With improved technologies, biomarkers, failed drugs may come into their own

BioWorld

At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...

Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

Small-molecule TREM2 agonist advances to treat Alzheimer’s

BioWorld Science

Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 31, 2026